Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
359 Results Found
AHA blog: PhRMA report misleads on drug costs
Instead of attacking hospitals and health systems caring for patients during the COVID-19 pandemic, PhRMA should instead focus on lowering the costs of drugs for Americans, writes AHA Executive Vice President Tom Nickels.
PhRMA report misleads on drug costs
America’s hospitals and health systems, and our heroic caregivers, have been on the front lines of the battle against COVID-19 for the past year, working tirelessly to provide needed care to patients and communities.
AHA urges CMS to withdraw Most Favored Nation rule
AHA today urged the Centers for Medicare & Medicaid Services to immediately withdraw its Most Favored Nation model interim final rule and “replace it with a serious effort at drug pricing reform.”
AHA Urges CMS to Withdraw Most Favored Nation Rule
AHA urges the Centers for Medicare & Medicaid Services to immediately withdraw its Most Favored Nation model interim final rule and “replace it with a serious effort at drug pricing reform.
AHA Statement on Court Delay of Most Favored Nation Model Interim Final Rule
AHA statement on court delay of most favored nation model interim final rule from Executive Vice President Tom Nickels.
AHA 340B Advocacy Alliance Bulletin: Attorneys general urge HHS to hold responsible drug manufacturers not providing 340B discounts
Attorneys general in 27 states and Washington, D.C., today
AHA moves to support legal challenge to CMS drug pricing model
The AHA filed a declaration supporting other organizations seeking a temporary restraining order and preliminary injunction to prevent the Centers for Medicare & Medicaid Services from cutting under its Most Favored Nation Model payments for certain Medicare Part B drugs and biologicals to no more than the lowest price that drug manufacturers receive in other similar countries.
AHA Declaration in Support of Legal Challenge to CMS Drug Pricing Model
The AHA filed a declaration supporting other organizations seeking a temporary restraining order and preliminary injunction to prevent the Centers for Medicare & Medicaid Services from cutting under its Most Favored Nation Model payments for certain Medicare Part B drugs and biologicals to no more than the lowest price that drug manufacturers receive in other similar countries.
Special Bulletin: CMS Issues Interim Final Rule Implementing Most Favored Nation Model for Part B Drugs
The Centers for Medicare & Medicaid Services (CMS) Nov.
Trump administration unveils two drug pricing policies
The Trump administration announced two actions that it claims will lower prescription drug prices.